Akili Inc. (AKLI) Financial Statements (2024 and earlier)

Company Profile

Business Address 71 COMMERCIAL STREET
BOSTON, MA 02109
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments75,15086,281105,842117,440136,131156,357
Cash and cash equivalents75,15073,79956,26687,86954,09789,661
Short-term investments  12,48249,57629,57182,03466,696
Restricted cash and investments305305305305305305
Receivables30044284494130
Prepaid expense 1,008 385 1,8922,107
Other current assets 1,267 1,633 1,9761,650
Other undisclosed current assets 3,6084753,531697829
Total current assets:78,03090,636108,724121,325141,042161,278
Noncurrent Assets
Operating lease, right-of-use asset1,5771,7531,9292,4272,5962,760
Property, plant and equipment680644715844919996
Other undisclosed noncurrent assets96109951  
Total noncurrent assets:2,3532,5062,7393,2723,5153,756
TOTAL ASSETS:80,38393,142111,463124,597144,557165,034
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,6114,6024,6844,2418,29713,032
Employee-related liabilities3,306
Accounts payable1,2851,2171,4571,4132,6813,486
Accrued liabilities3,3263,3853,2272,8285,6166,240
Deferred revenue100173176120106109
Debt7,5007,5007,5006,2504,3752,500
Deferred rent credit      2
Other undisclosed current liabilities756774791809826(2,503)
Total current liabilities:12,96713,04913,15111,42013,60413,140
Noncurrent Liabilities
Long-term debt and lease obligation5,4997,2088,90810,59412,27616,922
Long-term debt, excluding current maturities5,4997,2088,90810,59412,27614,221
Liabilities, other than long-term debt1,7531,9502,1442,3072,485 
Other liabilities232222   
Operating lease, liability1,7301,9282,1222,3072,4852,701
Other undisclosed noncurrent liabilities1,6321,8414,2977,8365,5138,399
Total noncurrent liabilities:8,88410,99915,34920,73720,27428,022
Total liabilities:21,85124,04828,50032,15733,87841,162
Equity
Equity, attributable to parent58,53269,09482,96392,440110,679123,872
Common stock888888
Additional paid in capital358,305357,720355,738353,429350,980347,330
Accumulated other comprehensive income (loss)   (25)2(21)7
Accumulated deficit(299,781)(288,634)(272,758)(260,999)(240,288)(223,473)
Total equity:58,53269,09482,96392,440110,679123,872
TOTAL LIABILITIES AND EQUITY:80,38393,142111,463124,597144,557165,034

Income Statement (P&L) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Revenues74970211411311182
Cost of revenue(252)(280)(150)(137)(125)(123)
Gross profit:497422(36)(24)(14)(41)
Operating expenses(12,120)(18,848)(15,281)(19,095)(22,093)(24,465)
Operating loss:(11,623)(18,426)(15,317)(19,119)(22,107)(24,506)
Nonoperating income (expense)5292,5503,558(1,592)5,31177,742
Other nonoperating income8671,0041,1261,0431,087346
Interest and debt expense(519)(582)(635)(622)(618)(496)
Income (loss) from continuing operations before equity method investments, income taxes:(11,613)(16,458)(12,394)(21,333)(17,414)52,740
Other undisclosed income from continuing operations before income taxes519582635622618496
Income (loss) from continuing operations before income taxes:(11,094)(15,876)(11,759)(20,711)(16,796)53,236
Other undisclosed loss from continuing operations (53)   (19) 
Income (loss) from continuing operations:(11,147)(15,876)(11,759)(20,711)(16,815)53,236
Income before gain (loss) on sale of properties:53,236
Net income (loss) attributable to parent:(11,147)(15,876)(11,759)(20,711)(16,815)53,236
Preferred stock dividends and other adjustments     (7,383)(2,397)
Other undisclosed net income available to common stockholders, basic    7,383 
Net income (loss) available to common stockholders, basic:(11,147)(15,876)(11,759)(20,711)(16,815)50,839
Other undisclosed net income available to common stockholders, diluted      2,397
Net income (loss) available to common stockholders, diluted:(11,147)(15,876)(11,759)(20,711)(16,815)53,236

Comprehensive Income ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net income (loss):(11,147)(15,876)(11,759)(20,711)(16,815)53,236
Other comprehensive income  252723 14
Other undisclosed comprehensive income (loss) 21   (21) 
Comprehensive income (loss):(11,126)(15,851)(11,732)(20,688)(16,836)53,250
Other undisclosed comprehensive loss, net of tax, attributable to parent (21) (54) (7) 
Comprehensive income (loss), net of tax, attributable to parent:(11,147)(15,851)(11,786)(20,688)(16,843)53,250

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: